Combined hydergin and pantesin therapy of acute apoplexies, its sequelae, and diffuse sclerotic encephalopathies.
D062365:Aminobenzoates / Q000627:therapeutic use*; D002543:Cerebral Hemorrhage / Q000188:drug therapy*; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D002549:Diffuse Cerebral Sclerosis of Schilder / Q000188:drug therapy*; D004877:Ergoloid Mesylates / Q000627:therapeutic use*; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000188:drug therapy*; D013451:Sulfonic Acids / Q000627:therapeutic use*
D062365:Aminobenzoates; D013451:Sulfonic Acids; D004877:Ergoloid Mesylates